Overview Dividends

(XPEV) Xpeng - Ratings and Ratios

Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US98422D1054

Electric, Sedan, SUV, MPV, Platform

Automobile Manufacturers
Market Cap in USD: 19,909m

IPO / Inception: 2020-08-27
Return 12m vs S&P 500: 54.5%

EPS (Earnings per Share)

EPS CAGR: 9.10%
EPS Trend: 70.1%

Last SUE: 0.49
Qual. Beats: 0

Revenue

Rev. CAGR: 26.04%
Rev. Trend: 72.3%

Last SUE: 0.00
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 10d forecast
Volatility	69.9%
Value at Risk 5%th	108%
Relative Tail Risk	-5.88%

Reward TTM
Sharpe Ratio	1.16
Alpha	64.21
CAGR/Max DD	0.40

Character TTM
Hurst Exponent	0.416
Beta	0.803
Beta Downside	0.640

Drawdowns 3y
Max DD	71.65%
Mean DD	34.41%
Median DD	29.26%

Description: XPEV Xpeng October 16, 2025

XPeng Inc. (NYSE:XPEV) designs, develops, manufactures, and markets a portfolio of smart electric vehicles (EVs) in China, including the P7/P7i sports sedan, G9 and G6 SUVs, X9 seven-seater MPV, MONA M03 hatchback coupe, and the performance-oriented P7+. The firm also supplies its proprietary XOS Tianji in-car operating system, the SEPA 2.0 electric platform, and a suite of ancillary services such as supercharging, maintenance, insurance tech, and auto-financing.

Recent data (Q3 2024) show XPeng delivered roughly 38,000 vehicles, a year-over-year increase of about 30 % and the strongest growth among domestic EV makers, while R&D spending rose to ~4.5 billion RMB, reflecting its push on autonomous driving and battery-efficiency technologies. The Chinese EV market is expanding at ~20 % CAGR, but the pace of government subsidies is tapering, making cost-competitiveness and software differentiation increasingly critical for market share.

For a deeper, data-driven assessment of XPeng’s valuation dynamics-including forward-looking cash-flow models and scenario analysis-consider exploring the detailed analyst toolkit on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (-2.85b TTM) > 0 and > 6% of Revenue (6% = 4.23b TTM)

FCFTA -0.05 (>2.0%) and ΔFCFTA -2.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.05% (prev 31.59%; Δ -22.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.02 (>3.0%) and CFO -2.01b > Net Income -2.85b (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (476.3m) change vs 12m ago -74.77% (target <= -2.0% for YES)

Gross Margin 17.08% (prev 11.45%; Δ 5.63pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 80.77% (prev 49.47%; Δ 31.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -5.53 (EBITDA TTM -1.32b / Interest Expense TTM 553.2m) >= 6 (WARN >= 3)

Altman Z'' -1.87

(A) 0.06 = (Total Current Assets 59.95b - Total Current Liabilities 53.57b) / Total Assets 98.31b

(B) -0.44 = Retained Earnings (Balance) -43.13b / Total Assets 98.31b

(D) -0.60 = Book Value of Equity -41.08b / Total Liabilities 68.32b

Total Rating: -1.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 38.81

1. Piotroski 3.50pt

2. FCF Yield -3.15%

3. FCF Margin -6.29%

4. Debt/Equity 1.16

5. Debt/Ebitda -12.96

6. ROIC - WACC (= -13.21)%

7. RoE -9.33%

8. Rev. Trend 72.32%

9. EPS Trend 70.06%

What is the price of XPEV shares?

As of November 28, 2025, the stock is trading at USD 21.14 with a total of 9,481,200 shares traded.
Over the past week, the price has changed by +5.23%, over one month by -8.17%, over three months by -6.87% and over the past year by +77.50%.

Is XPEV a buy, sell or hold?

Xpeng has received a consensus analysts rating of 4.21. Therefore, it is recommended to buy XPEV.

Strong Buy: 14
Buy: 7
Hold: 6
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the XPEV price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	28.2	33.3%
Analysts Target Price	28.2	33.3%
ValueRay Target Price	20.8	-1.8%

XPEV Fundamental Data Overview November 23, 2025

Market Cap CNY = 140.95b (19.91b USD * 7.0798 USD.CNY)
P/E Forward = 50.2513
P/S = 0.2821
P/B = 4.5384
Beta = 1.045
Revenue TTM = 70.57b CNY
EBIT TTM = -3.06b CNY
EBITDA TTM = -1.32b CNY
Long Term Debt = 6.42b CNY (from longTermDebt, last quarter)
Short Term Debt = 23.23b CNY (from shortTermDebt, last quarter)
Debt = 34.70b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.17b CNY (from netDebt column, last quarter)
Enterprise Value = 140.95b CNY (140.95b + Debt 34.70b - CCE 34.70b)
Interest Coverage Ratio = -5.53 (Ebit TTM -3.06b / Interest Expense TTM 553.2m)
FCF Yield = -3.15% (FCF TTM -4.44b / Enterprise Value 140.95b)
FCF Margin = -6.29% (FCF TTM -4.44b / Revenue TTM 70.57b)
Net Margin = -4.04% (Net Income TTM -2.85b / Revenue TTM 70.57b)
Gross Margin = 17.08% ((Revenue TTM 70.57b - Cost of Revenue TTM 58.52b) / Revenue TTM)
Gross Margin QoQ = 20.14% (prev 17.33%)
Tobins Q-Ratio = 1.43 (Enterprise Value 140.95b / Total Assets 98.31b)
Interest Expense / Debt = 0.29% (Interest Expense 99.3m / Debt 34.70b)
Taxrate = 1.83% (-7.11m / -388.0m)
NOPAT = -3.00b (EBIT -3.06b * (1 - 1.83%)) [loss with tax shield]
Current Ratio = 1.12 (Total Current Assets 59.95b / Total Current Liabilities 53.57b)
Debt / Equity = 1.16 (Debt 34.70b / totalStockholderEquity, last quarter 29.99b)
Debt / EBITDA = -12.96 (negative EBITDA) (Net Debt 17.17b / EBITDA -1.32b)
Debt / FCF = -3.87 (negative FCF - burning cash) (Net Debt 17.17b / FCF TTM -4.44b)
Total Stockholder Equity = 30.58b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.90% (Net Income -2.85b / Total Assets 98.31b)
RoE = -9.33% (Net Income TTM -2.85b / Total Stockholder Equity 30.58b)
RoCE = -8.27% (EBIT -3.06b / Capital Employed (Equity 30.58b + L.T.Debt 6.42b))
RoIC = -5.95% (negative operating profit) (NOPAT -3.00b / Invested Capital 50.47b)
WACC = 7.25% (E(140.95b)/V(175.65b) * Re(8.97%) + D(34.70b)/V(175.65b) * Rd(0.29%) * (1-Tc(0.02)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.13%
Fair Price DCF = unknown (Cash Flow -4.44b)
EPS Correlation: 70.06 | EPS CAGR: 9.10% | SUE: 0.49 | # QB: 0
Revenue Correlation: 72.32 | Revenue CAGR: 26.04% | SUE: -0.00 | # QB: 0

Additional Sources for XPEV Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle